Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Atherosclerotic cardiovascular disease (3)
- ASCVD (2)
- ASCVD Prevention (1)
- ASCVD Risk assessment (1)
- Adiposopathy (1)
-
- Atherosclerosis (1)
- Blood pressure (1)
- CD (1)
- CI (1)
- COVID-19 (1)
- CRF (1)
- Cardiovascular disease (1)
- Cardiovascular disease risk factors (1)
- Cardiovascular risk factors (1)
- Confidence interval (1)
- Crohn's disease (1)
- Diabetes (1)
- Epidemiology (1)
- Ethnic (1)
- Genetics/familial hypercholesterolemia (1)
- Glucose (1)
- Healthcare resource utilization (1)
- Hypertension (1)
- Influenza vaccine (1)
- Kidneys (1)
- Lipid-lowering therapy (1)
- Lipids (1)
- Nutrition; Obesity; Physical activity (1)
- Prevention (1)
- Preventive cardiology (1)
Articles 1 - 6 of 6
Full-Text Articles in Cardiology
Same Evidence, Varying Viewpoints: Three Questions Illustrating Important Differences Between United States And European Cholesterol Guideline Recommendations, David I. Feldman, Erin D. Michos, Neil J. Stone, Ty J. Gluckman, Miguel Cainzos-Achirica, Salim S. Virani, Roger S. Blumenthal
Same Evidence, Varying Viewpoints: Three Questions Illustrating Important Differences Between United States And European Cholesterol Guideline Recommendations, David I. Feldman, Erin D. Michos, Neil J. Stone, Ty J. Gluckman, Miguel Cainzos-Achirica, Salim S. Virani, Roger S. Blumenthal
Office of the Provost
In 2018, the AHA/ACC Multisociety Guideline on the Management of Blood Cholesterol was released. Less than one year later, the 2019 ESC/EAS Dyslipidemia Guideline was published. While both provide important recommendations for managing atherosclerotic cardiovascular disease (ASCVD) risk through lipid management, differences exist. Prior to the publication of both guidelines, important randomized clinical trial data emerged on non-statin lipid lowering therapy and ASCVD risk reduction. To illustrate important differences in guideline recommendations, we use this data to help answer three key questions: 1) Are ASCVD event rates similar in high-risk primary and stable secondary prevention? 2) Does imaging evidence of …
Shared Decision Making And Patient Reported Outcomes Among Adults With Atherosclerotic Cardiovascular Disease, Medical Expenditure Panel Survey 2006-2015, Victor Okunrintemi, Javier Valero-Elizondo, Neil J. Stone, Ron Blankstein, Michael J. Blaha, Martha Gulati, Salim S. Virani, William A. Zoghbi, Erin D. Michos, Khurram Nasir
Shared Decision Making And Patient Reported Outcomes Among Adults With Atherosclerotic Cardiovascular Disease, Medical Expenditure Panel Survey 2006-2015, Victor Okunrintemi, Javier Valero-Elizondo, Neil J. Stone, Ron Blankstein, Michael J. Blaha, Martha Gulati, Salim S. Virani, William A. Zoghbi, Erin D. Michos, Khurram Nasir
Office of the Provost
Importance: Shared decision-making (SDM), one of the pillars of patient centered care is strongly encouraged and has been incorporated into the management of atherosclerotic cardiovascular disease (ASCVD) but the expansion of its use has been limited.
Objective: To determine the association of SDM on patient-reported health status, measures of quality of care, healthcare resource utilization, and healthcare spending among US adults with ASCVD.
Method: This is a retrospective cohort study in an ambulatory setting, utilizing the Medical Expenditure Panel Survey (MEPS) 2006-2015. Analysis completed in December 2020. Participants included were adults 18 years and over with a diagnosis of ASCVD. …
Prevalence Of Cardiovascular Risk Factors In A Nationally Representative Adult Population With Inflammatory Bowel Disease Without Atherosclerotic Cardiovascular Disease, Tanushree Agrawal, Isaac Acquah, Amit K. Dey, Kerri Glassner, Bincy Abraham, Ron Blankstein, Salim S. Virani, Michael J. Blaha, Javier Valero-Elizondo, Nehal Mehta
Prevalence Of Cardiovascular Risk Factors In A Nationally Representative Adult Population With Inflammatory Bowel Disease Without Atherosclerotic Cardiovascular Disease, Tanushree Agrawal, Isaac Acquah, Amit K. Dey, Kerri Glassner, Bincy Abraham, Ron Blankstein, Salim S. Virani, Michael J. Blaha, Javier Valero-Elizondo, Nehal Mehta
Office of the Provost
Background and aims: Chronic inflammation is associated with premature atherosclerotic cardiovascular disease (ASCVD). We studied the prevalence of cardiovascular risk factors (CRFs) amongst individuals with IBD who have not developed ASCVD.
Methods: Our study population was derived from the 2015 - 2016 National Health Interview Survey. Those with ASCVD (defined as myocardial infarction, angina or stroke) were excluded. The prevalence of CRFs among individuals with IBD was compared with those without IBD. The odds CRFs among adults with IBD was assessed using logistic regression models.
Results: In our study population of 60,155 individuals, 786 (1.3%) had IBD. IBD was associated …
Racial And Geographic Disparities In Influenza Vaccination In The U.S. Among Individuals With Atherosclerotic Cardiovascular Disease: Renewed Importance In The Setting Of Covid-19, Mahmoud Al Rifai, Umair Khalid, Arunima Misra, Jing Liu, Khurram Nasir, Miguel Cainzos-Achirica, Dhruv Mahtta, Christie M. Ballantyne, Laura A. Petersen, Salim S. Virani
Racial And Geographic Disparities In Influenza Vaccination In The U.S. Among Individuals With Atherosclerotic Cardiovascular Disease: Renewed Importance In The Setting Of Covid-19, Mahmoud Al Rifai, Umair Khalid, Arunima Misra, Jing Liu, Khurram Nasir, Miguel Cainzos-Achirica, Dhruv Mahtta, Christie M. Ballantyne, Laura A. Petersen, Salim S. Virani
Office of the Provost
Introduction: The importance of receiving an annual influenza vaccine among patients with atherosclerotic cardiovascular disease (ASCVD) is well established. With the rapid community spread and the possibility of another wave of COVID-19 infections in the fall, receiving an influenza vaccine is of particular importance to mitigate the risk associated with overlapping influenza and COVID-19 infections.
Methods: We utilized cross-sectional data from the 2016 to 2019 Behavioral Risk Factor Surveillance System (BRFSS), a nationally representative U.S. telephone-based survey of adults 18 years or older. Race/ethnicity was our exposure of interest. We assessed the relative difference in influenza vaccination by race/ethnicity for …
Hypertension Guidelines And Coronary Artery Calcification Among South Asians: Results From Masala And Mesa, Jaideep Patel, Anurag Mehta, Mahmoud Al Rifai, Michael J. Blaha, Khurram Nasir, John W. Mcevoy, Ambarish Pandey, Alka M. Kanaya, Namratha R. Kandula, Salim S. Virani
Hypertension Guidelines And Coronary Artery Calcification Among South Asians: Results From Masala And Mesa, Jaideep Patel, Anurag Mehta, Mahmoud Al Rifai, Michael J. Blaha, Khurram Nasir, John W. Mcevoy, Ambarish Pandey, Alka M. Kanaya, Namratha R. Kandula, Salim S. Virani
Office of the Provost
Untreated hypertension may contribute to increased atherosclerotic cardiovascular disease (ASCVD) risk in South Asians (SA). We assessed HTN prevalence among untreated adults free of baseline ASCVD from the MASALA & MESA studies. The proportion of participants who received discordant recommendations regarding antihypertensive pharmacotherapy use by the 2017-ACC/AHA and JNC7 Guidelines across CAC score categories in each race/ethnic group was calculated. Compared with untreated MESA participants (n = 3896), untreated SA (n = 445) were younger (55±8 versus 59±10 years), had higher DBP (73±10 versus 70±10 mmHg), total cholesterol (199±34 versus 196±34 mg/dL), statin use (16% versus 9%) and …
Ten Things To Know About Ten Cardiovascular Disease Risk Factors, Harold E. Bays, Pam R. Taub, Elizabeth Epstein, Erin D. Michos, Richard A. Ferraro, Alison Bailey, Heval M. Kelli, Keith C. Ferdinand, Melvin R. Echols, Salim S. Virani
Ten Things To Know About Ten Cardiovascular Disease Risk Factors, Harold E. Bays, Pam R. Taub, Elizabeth Epstein, Erin D. Michos, Richard A. Ferraro, Alison Bailey, Heval M. Kelli, Keith C. Ferdinand, Melvin R. Echols, Salim S. Virani
Office of the Provost
Given rapid advancements in medical science, it is often challenging for the busy clinician to remain up-to-date on the fundamental and multifaceted aspects of preventive cardiology and maintain awareness of the latest guidelines applicable to cardiovascular disease (CVD) risk factors. The "American Society for Preventive Cardiology (ASPC) Top Ten CVD Risk Factors 2021 Update" is a summary document (updated yearly) regarding CVD risk factors. This "ASPC Top Ten CVD Risk Factors 2021 Update" summary document reflects the perspective of the section authors regarding ten things to know about ten sentinel CVD risk factors. It also includes quick access to sentinel …